{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:38:56Z","timestamp":1786419536647,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874296"],"award-info":[{"award-number":["81874296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bmc.2021.116466","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T01:55:49Z","timestamp":1634176549000},"page":"116466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP+) as a carrier"],"prefix":"10.1016","volume":"50","author":[{"given":"Huina","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmc.2021.116466_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2021.116466_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/fmc.12.190","article-title":"Targeting cancer cell mitochondria as a therapeutic approach","volume":"5","author":"Wen","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcell.2015.00043","article-title":"Cancer as a mitochondrial metabolic disease","volume":"3","author":"Seyfried","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmc.2021.116466_b0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and cancer","volume":"61","author":"Zong","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2021.116466_b0025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ijc.25944","article-title":"Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells","volume":"129","author":"Ye","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmc.2021.116466_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A Mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmc.2021.116466_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2009.12.003","article-title":"Small mitochondria-targeting molecules as anti-cancer agents","volume":"31","author":"Wang","year":"2010","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmc.2021.116466_b0040","doi-asserted-by":"crossref","first-page":"11786","DOI":"10.1021\/acs.jmedchem.0c00881","article-title":"Anticancer effects of honokiol via mitochondrial dysfunction are strongly enhanced by the mitochondria-targeting carrier berberine","volume":"63","author":"Shi","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2021.116466_b0045","article-title":"A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116466_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bioorg.2018.12.036","article-title":"Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs","volume":"85","author":"Jin","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0055","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1021\/mp500038g","article-title":"Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435\/DOX cells","volume":"11","author":"Han","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2021.116466_b0060","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells","volume":"276","author":"Kelso","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0065","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1021\/acs.jmedchem.7b00679","article-title":"Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms","volume":"60","author":"Ye","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0070","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/ja00775a078","article-title":"Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii","volume":"94","author":"Kupchan","year":"1972","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2021.116466_b0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: Progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2021.116466_b0080","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3892\/ol.2016.5099","article-title":"Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549\/Taxol cells via modulation of MAPK and PI3K\/Akt signaling pathways","volume":"12","author":"Xie","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2021.116466_b0085","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3109\/13880209.2012.665931","article-title":"Triptolide modulates the sensitivity of K562\/A02 cells to adriamycin by regulating miR-21 expression","volume":"50","author":"Li","year":"2012","journal-title":"Pharm Biol"},{"issue":"2","key":"10.1016\/j.bmc.2021.116466_b0090","doi-asserted-by":"crossref","first-page":"e0171827","DOI":"10.1371\/journal.pone.0171827","article-title":"Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer","volume":"12","author":"Arora","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2021.116466_b0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4149\/neo_2013_077","article-title":"Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression","volume":"60","author":"Guo","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.bmc.2021.116466_b0100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.biopha.2018.05.088","article-title":"Broad targeting of triptolide to resistance and sensitization for cancer therapy","volume":"104","author":"Hou","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2021.116466_b0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.fct.2013.04.039","article-title":"Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats","volume":"58","author":"Wang","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bmc.2021.116466_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2019.10.001","article-title":"Triptolide dysregulates glucose uptake via inhibition of IKK\u03b2-NF-\u03baB pathway by p53 activation in cardiomyocytes","volume":"318","author":"Xi","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bmc.2021.116466_b0115","unstructured":"Fu ZQ, Zhou QQ, Shan B. Triptolide derivative and its preparation method and preparation. 201710157831.3, 2017."},{"key":"10.1016\/j.bmc.2021.116466_b0120","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.bmc.2010.01.052","article-title":"Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl","volume":"18","author":"Xu","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0125","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/jm900342g","article-title":"Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents","volume":"52","author":"Li","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.biopha.2018.04.198","article-title":"Biochemical and computational evaluation of Triptolide-induced cytotoxicity against NSCLC","volume":"103","author":"Hamdi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2021.116466_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2018.01.011","article-title":"Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3\u03b2 by increased SIRT3 expression","volume":"342","author":"Kong","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bmc.2021.116466_b0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3892\/ol.2013.1524","article-title":"Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species\/nuclear factor-\u03baB pathway in SKOV3PT platinum-resistant human ovarian cancer cells","volume":"6","author":"Zhong","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2021.116466_b0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2021.116466_b0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.toxlet.2014.08.017","article-title":"Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways","volume":"230","author":"Zhou","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bmc.2021.116466_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10565-018-9447-8","article-title":"Drp1-associated mitochondrial dysfunction and mitochondrial autophagy: a novel mechanism in triptolide-induced hepatotoxicity","volume":"35","author":"Hasnat","year":"2019","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.bmc.2021.116466_b0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/toxsci\/kfx144","article-title":"Characterization of triptolide-induced hepatotoxicity by imaging and transcriptomics in a novel zebrafish model","volume":"159","author":"Vliegenthart","year":"2017","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bmc.2021.116466_b0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","article-title":"Triptolide: Medicinal chemistry, chemical biology and clinical progress","volume":"176","author":"Hou","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116466_b0170","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: Syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem Rev"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621004740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:16:17Z","timestamp":1760836577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621004740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"alternative-id":["S0968089621004740"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116466","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP+) as a carrier","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116466"}}